Friday, February 20, 2026
21 C
Bengaluru

Partner Don’t Punish

[wpfilebase tag=file id=74 tpl=download-button /]

Inside this Issue

1. Three Simple Ways to Step Up Your Role as a Firstline Leaders by Vivek Hattangadi

Using Empathy, Focus and Presentation to earn the confidence of your team and produce outstanding results.

2. What Makes a Brand Management Strategy Successful? by Genesh Kuriakose

What every Pharma Brand Manager needs to know about crafting a successful Brand Strategy over the lifecycle of a product.

3. Application of Porter’s 5 to Pharma Marketing by Pankaj Mehrotra

A tried-and-tested competition analysis framework, applied seamlessly to pharma.

4. Market and Morals in Pharma by Salil Kallianpur

Free markets are by nature amoral. To get moral (or ’just’) outcomes from an amoral market requires a well-developed governance system – which India presently lacks.

5. NOT Business as Usual by Jay Mehta

How the New Generation of Pharma Professionals Will Embrace Change and Disruption.

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img